A recent JAMA study from University of Texas MD Anderson Cancer Center researchers found no correlation between intensity of post-treatment surveillance and detection of recurrence or survival in patients with stage I, II or III colorectal cancer (CRC).

Researchers have successfully used robot-assisted multispectral-fluorescence imaging to distinguish between healthy and diseased lymphatic flow patterns.

New research has found fetal MRI can reliably identify holoprosencephaly as early as 18 weeks into pregnancy, providing added time for parents to understand and prepare for the condition.

The structure and activity in transgender teens’ brains more closely resemble their desired gender than their biological sex, according to research presented at the European Society of Endocrinology’s annual symposium in Barcelona.

The brain activity of individuals questioning gender identity may resemble those of their desired gender, according to an article published May 22 by The Telegraph.  

Fetal MRI can accurately diagnose holoprosencephaly as early as 18 weeks into a pregnancy, researchers from the Children’s National Health System in Washington, D.C., reported this week, providing parents with added time to prepare for the realities of caring for a child with complex care needs.

Though not the guideline-recommended route for treatment, select breast cancer patients could benefit greatly from MRI screenings designed to identify brain metastases, according to a research letter penned this month by Dana-Farber/Brigham and Women’s Cancer Center experts and published in JAMA Oncology.

A team of scientists found therapeutic treatment using radiopharmaceutical I-131 mIBG can effectively mitigate symptoms of certain neuroendocrine tumors and resulted in improved prognosis for patients with symptomatic progression, radiographic response or stability and biochemical response.